Updated WG5 goals

WG5 – Clinical Translation and Personalisation

What we’ve done so far:
WG5 has initiated work on dose-effect relationships, identified relevant biomarkers and dose predictors, and started developing approaches for standardised toxicity reporting.

What we aim to do next:
Future efforts will focus on refining radiobiological models, defining dose constraints, and establishing standardised data formats to support multicentre studies and clinical translation.